熱門資訊> 正文
CRVS、CTMX和NRXP均为上市前涨幅股
2024-05-06 20:39
- Gainers: XBP Europe Holdings (XBP) +68%.
- Perficient (PRFT) +53% Q1 earnings call release
- Strong Global Entertainment (SGE) +52% to acquire Strong/MDI Screen Systems
- Beneficient (BENF) +19%.
- Allarity Therapeutics (ALLR) +13% Exceeds Nasdaq’s Minimum Equity Requirement; Requests Voluntarily Withdrawal of Form S-1.
- Integrated Media Technology (IMTE) +17%.
- Holdco Nuvo Group (NUVO) +15%.
- ZyVersa Therapeutics (ZVSA) +13%.
- Plus Therapeutics (PSTV) +12% looks to raise $18 million through private placement
- Biocryst Pharmaceuticals (BCRX) +11% Q1 earnings call release
- Lilium (LILM) +11% wins order for 20 electric jets from UrbanLink.
- Gorilla Technology Group (GRRR) +11% Strategic Alliance to Pioneer Advanced Manufacturing Hub in Egypt.
- OptiNose (OPTN) +9%.
- Outset Medical (OM) +10% Prefiltration Receives FDA 510(k) Clearance.
- NRX Pharmaceuticals (NRXP) +10%.
- Freshpet (FRPT) +10% Q1 earnings call release
- Corvus Pharmaceuticals (CRVS) +9%.
- N2OFF (NITO) +9%.
- Psyence Biomedical (PBM) +9%.
- Intercure (INCR) +8%.
- Li Auto (LI) +7%.
- NanoViricides (NNVC) +7% Antiviral with Activity Against Influenza A.
- Zentek (ZTEK) +7% achieves positive results against H5N1 using multivalent aptamer technology.
- Microstrategy (MSTR) +7% gain after Bitcoin reclaims the $65K level, altcoins follow suit.
- CytomX Therapeutics (CTMX) +7%.
More on premarket gainers & stock
- CytomX: CX-904 Tumor Treatment Data Might Get Ball Rolling
- CytomX Therapeutics: I'm Bullish; There's More Than One Masked Immunotherapy Company In Town
- NRX Pharmaceuticals, Inc. (NRXP) Q4 2023 Earnings Call Transcript
- Corvus stock gains amid pricing of $30.6M direct offering
- CytomX surges on upcoming data for Amgen-partnered cancer drug
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
